… (PD). Moreover, the appearance of olfactory dysfunction early in the clinical course of PD makes it an appealing research target as a biomarker. However, very little is … become a biomarker of disease progression that will allow researchers to determine if novel therapeutic interventions …

… About Us: The Michael J. Fox Foundation for Parkinson’s Research (MJFF) was founded in 2000 with a single defined … triple-pronged, singularly-defined strategy towards disease research enables a dynamic, motivated, and young organization. MJFF has quickly grown into the largest global funder of Parkinson’s disease …

… those tools and reagents that can be of greatest use to PD researchers. Working with Dr. R. Jude Samulski at The … for proper function in two independent laboratories using nearly identical techniques. Relevance to Diagnosis/Treatment of Parkinson’s Disease: Pre-clinical …

… arm of The Michael J. Fox Foundation for Parkinson’s Research (MJFF). Each year, more than 1,500 Team Fox members worldwide turn their passions and interests into unique fundraising events and athletic feats. Since our … have raised an astounding $15 million for Parkinson’s research, helping MJFF achieve its mission to speed new …

… risk of developing Parkinson's disease down the road, research hints. In a study, Dr. Walter A. Rocca at the Mayo … was evident long before the onset of the disease, the researchers note. "Indeed, the association remained … say the investigators, suggest that constipation is an early manifestation of the neurodegenerative process …

… The Research Alliances Intern will focus on analyzing the … Now About Us: The Michael J. Fox Foundation for Parkinson’s Research (MJFF) was founded in 2000 with one clear … organization. Since inception, MJFF has quickly grown into the largest nonprofit funder of Parkinson’s disease …